Literature DB >> 25805657

Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.

Tarek H Mouhieddine1, Hala Darwish1, Lama Fawaz1, Bassem Yamout1, Hani Tamim2, Samia J Khoury3.   

Abstract

Multiple sclerosis (MS) is an inflammatory demyelination of the central nervous system. We investigated the prevalence of EBV seropositivity and other known risk factors for MS (age, smoking, low vitamin D) and their effect on anti-EBV antibody titers. We retrospectively studied 249 MS patients receiving care at the American University of Beirut Medical Center and 230 controls, during 2010-2014. EBV seropositivity was higher in MS patients compared to controls for both anti-VCA (99.5%; 97.2%) and anti-EBNA-1 (96.3%; 89.4%), and the titers were significantly higher in MS patients. MS patients had a significantly lower vitamin D level (15.5 ± 8.3 ng/ml) compared to controls (20.4 ± 11.3 ng/ml). The proportion of heavy smokers and overweight individuals was significantly higher in MS patients. Lebanese MS patients have risk factors similar to those in western countries. Older age and female gender were associated with a higher anti-VCA titer and male gender with a higher anti-EBNA-1.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Epstein–Barr virus; Multiple sclerosis; Risk factors

Mesh:

Substances:

Year:  2015        PMID: 25805657     DOI: 10.1016/j.clim.2015.03.011

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  8 in total

1.  Effect of Vitamin D Replacement on Cognition in Multiple Sclerosis Patients.

Authors:  Hala Darwish; Ribal Haddad; Sahar Osman; Stephanie Ghassan; Bassem Yamout; Hani Tamim; Samia Khoury
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

2.  Primary Epstein-Barr virus infection with and without infectious mononucleosis.

Authors:  Klaus Rostgaard; Henry H Balfour; Ruth Jarrett; Christian Erikstrup; Ole Pedersen; Henrik Ullum; Lars Peter Nielsen; Marianne Voldstedlund; Henrik Hjalgrim
Journal:  PLoS One       Date:  2019-12-17       Impact factor: 3.240

3.  Little evidence for an effect of smoking on multiple sclerosis risk: A Mendelian Randomization study.

Authors:  Ruth E Mitchell; Kirsty Bates; Robyn E Wootton; Adil Harroud; J Brent Richards; George Davey Smith; Marcus R Munafò
Journal:  PLoS Biol       Date:  2020-11-30       Impact factor: 8.029

4.  Multiple sclerosis in the Middle East and North Africa region.

Authors:  Samia J Khoury; Mar Tintore
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-01-09

5.  Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study.

Authors:  María Inmaculada Domínguez-Mozo; Lorena López-Lozano; Silvia Pérez-Pérez; Ángel García-Martínez; María José Torrejón; Rafael Arroyo; Roberto Álvarez-Lafuente
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

6.  Evaluation of IL-1β and IL-6 Expression following EBNA-1 and BRLF-1 Peptide Treatment in Epstein-Barr Virus-Positive Multiple Sclerosis Patients.

Authors:  Roya Kianfar; Mehrdad Ravanshad; Mohammad Adel Ghiass; Nastaran Rafiee; Ali Shayeghpour; Ali Maleki
Journal:  Intervirology       Date:  2022-02-14       Impact factor: 2.294

7.  The Correlation between the Virus- and Brain Antigen-Specific B Cell Response in the Blood of Patients with Multiple Sclerosis.

Authors:  Marie Wunsch; Christopher Hohmann; Bianca Milles; Christina Rostermund; Paul V Lehmann; Michael Schroeter; Antonios Bayas; Jochen Ulzheimer; Mathias Mäurer; Süleyman Ergün; Stefanie Kuerten
Journal:  Viruses       Date:  2016-04-23       Impact factor: 5.048

Review 8.  MS in self-identified Hispanic/Latino individuals living in the US.

Authors:  Lilyana Amezcua; Jorge R Oksenberg; Jacob L McCauley
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.